Steven Cohen’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Steven Cohen’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-123,200	Closed	-$955K	–	2999
2023 Q3	$955K	Sell	123,200 -1,200	-1%	-$9.95K	﹤0.01%	1343
2023 Q2	$1.24M	Buy	124,400 +124,116	+43,703%	+$994K	﹤0.01%	1109
2023 Q1	$1.65K	Buy	+284	New	+$2.45K	﹤0.01%	2115

Other funds holding ICVX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Steven Cohen's ICVX Position: Q4 2023 in Review

Steven Cohen sold out of Icosavax, Inc. Common Stock (ICVX) in Q4 2023, closing a stake of 123,200 shares — an estimated $955K sold.

Steven Cohen first reported a position in ICVX in Q1 2023 and held it in 3 quarters. The position peaked at $1.24M in Q2 2023. 93 funds tracked by Wall St. Rank hold ICVX as of Q4 2023.

Steven Cohen reported no remaining Icosavax, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Steven Cohen sold 123,200 Icosavax, Inc. Common Stock shares in Q4 2023, an estimated $955K.
Steven Cohen first reported a position in Icosavax, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Steven Cohen's Icosavax, Inc. Common Stock position peaked at $1.24M in Q2 2023.
93 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.